Skip to Content
Merck

QSAR-based solubility model for drug-like compounds.

Bioorganic & medicinal chemistry (2010-09-03)
Rafael Gozalbes, Antonio Pineda-Lucena
ABSTRACT

Solubility plays a very important role in the selection of compounds for drug screening. In this context, a QSAR model was developed for predicting water solubility of drug-like compounds. First, a set of relevant parameters for establishing a drug-like chemical space was defined. The comparison of chemical structures from the FDAMDD and PHYSPROP databases allowed the selection of properties that were more efficient in discriminating drug-like compounds from other chemicals. These filters were later on applied to the PHYSPROP database and 1174 chemicals fulfilling these criteria and with experimental solubility information available at 25°C were retained. Several QSAR solubility models were developed from this set of compounds, and the best one was selected based on the accuracy of correct classifications obtained for randomly chosen training and validation subsets. Further validation of the model was performed with a set of 102 drugs for which experimental solubility data have been recently reported. A good agreement between the predictions and the experimental values confirmed the reliability of the QSAR model.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Ketoprofen, meets USP testing specifications
Sigma-Aldrich
Furosemide
Sigma-Aldrich
Ketoprofen, ≥98% (TLC)
Sigma-Aldrich
Nalidixic acid, ≥98%
Sigma-Aldrich
Amoxicillin, 95.0-102.0% anhydrous basis
Sigma-Aldrich
5,5-Diphenylhydantoin, ≥98%
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Sigma-Aldrich
Sulfamethazine, 99.0-101.0% (on dried basis)
Supelco
Thymol, analytical standard
Sigma-Aldrich
Thymol, meets analytical specification of Ph. Eur., BP, NF, 99-101%
Supelco
Tolbutamide, analytical standard
Supelco
Norfloxacin, analytical standard, ≥98% (TLC)
Sigma-Aldrich
Thymol, ≥98.5%
Sigma-Aldrich
Piroxicam, meets USP testing specifications
Sigma-Aldrich
Famotidine
Supelco
Sulfamerazine, VETRANAL®, analytical standard
Sigma-Aldrich
Sulfamerazine, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Ciprofloxacin, ≥98% (HPLC)
Sigma-Aldrich
Enrofloxacin, ≥99.0%
Sigma-Aldrich
Sparfloxacin, ≥98.0% (HPLC)
Sigma-Aldrich
Ethyl 4-aminobenzoate, 98%
Supelco
Ciprofloxacin, VETRANAL®, analytical standard
Supelco
Enrofloxacin, VETRANAL®, analytical standard
Sigma-Aldrich
2-Chloromandelic acid, 98%
Sigma-Aldrich
4-Hydroxybenzoic acid, ≥99%, FG
Sigma-Aldrich
Thymol, FCC, FG
Sigma-Aldrich
4-Hydroxybenzoic acid, ReagentPlus®, ≥99%
Sigma-Aldrich
4-Hydroxybenzoic acid, ReagentPlus®, 99%
Sigma-Aldrich
(1S,2S)-(+)-Pseudoephedrine, 98%